Uncategorized

Nitric Oxide Market Strategies and Forecasts, 2019 to 2025

Press Release

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

The global Nitric Oxide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nitric Oxide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nitric Oxide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nitric Oxide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nitric Oxide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Mallinckrodt

Request Sample Copy of This Report At https://www.marketresearchhub.com/enquiry.php?type=S&repid=2524341&source=atm
Praxair
Air Liquide

Segment by Regions
North America
Europe
China
Japan
Southeast Asia

Purchase a copy of This Report At https://www.marketresearchhub.com/checkout?rep_id=2524341&licType=S&source=atm
India

Segment by Type
99.92% Purity
99.99% Purity
Other

Segment by Application
ARDS
PPHN
Other Diseases

Make An Enquiry About This Report At https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2524341&source=atm

This post was originally published on Space Market Research

Tags

Related Articles

Close